The GsD model will allow the simulation of glucagon-like signaling specifically in hepatocytes independently of other metabolic changes associated with type 2 diabetes, such as hepatic lipid accumulation or pleiotropic effects of glucagon receptor signaling on metabolism (64), including direct actions on extrahepatic tissues such as brain (65). This evidence concerns the gene GCG and type 2 diabetes mellitus.